Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticlePatient Safety

Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants

D.S. Enterline, K.W Martin, H.A Parmar, F.M Triulzi and C. Colosimo
American Journal of Neuroradiology December 2019, 40 (12) 2001-2009; DOI: https://doi.org/10.3174/ajnr.A6319
D.S. Enterline
aFrom the Department of Radiology (D.S.E.), Duke University, Durham, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D.S. Enterline
K.W Martin
bDepartment of Diagnostic Imaging (K.W.M.), University of California, San Francisco, Benioff Children’s Hospital, Oakland, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K.W Martin
H.A Parmar
cDepartment of Radiology (H.A.P.), University of Michigan, C.S. Mott Children’s Hospital, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H.A Parmar
F.M Triulzi
dDepartment of Neuroradiology (F.M.T.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinic, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F.M Triulzi
C. Colosimo
eRadiodiagnostica e Neuroradiologia (C.C.), Institute of Radiology, Fondazione Policlinico Universitario ’A. Gemelli’, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Colosimo
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Nardone B,
    2. Saddleton E,
    3. Laumann AE, et al
    . Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol 2014;44:173–80 doi:10.1007/s00247-013-2795-x pmid:24057195
    CrossRefPubMed
  2. 2.↵
    American College of Radiology. ACR Manual on Contrast Media. Version 10.3. Reston: American College of Radiology; 2017
  3. 3.↵
    1. Bedoya MA,
    2. White AM,
    3. Edgar JC, et al
    . Effect of intravenous administration of contrast media on serum creatinine levels in neonates. Radiology 2017;284:530–40 doi:10.1148/radiol.2017160895 pmid:28387639
    CrossRefPubMed
  4. 4.↵
    1. Roberts DR,
    2. Chatterjee AR,
    3. Yazdani M, et al
    . Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol 2016;37:2340–47 doi:10.3174/ajnr.A4891 pmid:27469211
    Abstract/FREE Full Text
  5. 5.↵
    1. Hu HH,
    2. Pokorney A,
    3. Towbin RB, et al
    . Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol 2016;46:1590–98 doi:10.1007/s00247-016-3646-3 pmid:27282825
    CrossRefPubMed
  6. 6.↵
    1. Flood TF,
    2. Stence NV,
    3. Maloney JA, et al
    . Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 2017;282:222–28 doi:10.1148/radiol.2016160356 pmid:27467467
    CrossRefPubMed
  7. 7.↵
    1. Radbruch A,
    2. Haase R,
    3. Kickingereder P, et al
    . Pediatric brain: no increased signal intensity in the dentate nucleus on unenhanced T1-weighted MR images after consecutive exposure to a macrocyclic gadolinium-based contrast agent. Radiology 2017;283:828–36 doi:10.1148/radiol.2017162980 pmid:28273007
    CrossRefPubMed
  8. 8.↵
    1. Blumfield E,
    2. Moore MM,
    3. Drake MK, et al
    . Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report. Pediatr Radiol 2017;47:665–73 doi:10.1007/s00247-017-3807-z pmid:28283728
    CrossRefPubMed
  9. 9.↵
    1. Rossi Espagnet MC,
    2. Bernardi B,
    3. Pasquini L, et al
    . Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children. Pediatr Radiol 2017;47:1345–52 doi:10.1007/s00247-017-3874-1 pmid:28526896
    CrossRefPubMed
  10. 10.↵
    1. Gulani V,
    2. Calamante F,
    3. Shellock FG, et al
    ; International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 2017;16:564–70 doi:10.1016/S1474-4422(17)30158-8 pmid:28653648
    CrossRefPubMed
  11. 11.↵
    1. Kirchin MA,
    2. Pirovano G,
    3. Venetianer C, et al
    . Safety assessment of gadobenate dimeglumine (Multihance®): extended clinical experience from Phase I studies to post-marketing surveillance. J Magn Reson Imaging 2001;14:281–94 doi:10.1002/jmri.1184 pmid:11536405
    CrossRefPubMed
  12. 12.↵
    1. Shellock FG,
    2. Parker JR,
    3. Venetianer C, et al
    . Safety of gadobenate dimeglumine: summary of findings from clinical studies and post-marketing surveillance. Invest Radiol 2006;41:500–09 doi:10.1097/01.rli.0000209661.99225.c2 pmid:16763468
    CrossRefPubMed
  13. 13.↵
    1. Bleicher AG,
    2. Kanal E.
    Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. AJR Am J Roentgenol 2008;191:W307–11 doi:10.2214/AJR.07.3951 pmid:19020220
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. Schneider G,
    2. Schürholz H,
    3. Kirchin MA, et al
    . Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol 2013;43:202–11 doi:10.1007/s00247-012-2498-8 pmid:23179483
    CrossRefPubMed
  15. 15.↵
    1. Shen Y,
    2. Goerner FL,
    3. Snyder C, et al
    . T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Invest Radiol 2015;50:330–08 doi:10.1097/RLI.0000000000000132 pmid:25658049
    CrossRefPubMed
  16. 16.↵
    1. Colosimo C,
    2. Demaerel P,
    3. Tortori-Donati P, et al
    . Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in pediatric subjects. Pediatr Radiol 2005;35:501–10 doi:10.1007/s00247-004-1392-4 pmid:15678342
    CrossRefPubMed
  17. 17.↵
    1. Schneider G,
    2. Maas R,
    3. Schultze Kool L, et al
    . Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 2003;38:85–94 doi:10.1097/00004424-200302000-00003 pmid:12544071
    CrossRefPubMed
  18. 18.↵
    1. Nandwana SB,
    2. Moreno CC,
    3. Osipow MT, et al
    . Gadobenate dimeglumine administration and nephrogenic systemic fibrosis: is there a real risk in patients with impaired renal function? Radiology 2015;276:741–47 doi:10.1148/radiol.2015142423 pmid:25875973
    CrossRefPubMed
  19. 19.↵
    1. Bruce R,
    2. Wentland AL,
    3. Haemel AK, et al
    . Incidence of nephrogenic systemic fibrosis using gadobenate dimeglumine in 1423 patients with renal insufficiency compared with gadodiamide. Invest Radiol 2016;51:701–05 doi:10.1097/RLI.0000000000000259 pmid:26885631
    CrossRefPubMed
  20. 20.↵
    1. Schneider GK,
    2. Stroeder J,
    3. Roditi G, et al
    . T1 signal measurements in pediatric brain: findings after multiple exposures to gadobenate dimeglumine for imaging of nonneurologic disease. AJNR Am J Neuroradiol 2017;38:1799–806 doi:10.3174/ajnr.A5270 pmid:28642266
    Abstract/FREE Full Text
  21. 21.↵
    1. Kinner S,
    2. Schubert TB,
    3. Bruce RJ, et al
    . Deep brain nuclei T1 shortening after gadobenate dimeglumine in children: influence of radiation and chemotherapy. AJNR Am J Neuroradiol 2018;39:24–30 doi:10.3174/ajnr.A5453 pmid:29146718
    Abstract/FREE Full Text
  22. 22.↵
    MultiHance prescribing information in the USA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s016s017,021358s015s016lbl.pdf. Accessed September 5, 2019
  23. 23.↵
    1. Elster AD,
    2. Moody DM,
    3. Ball MR
    et al. Is Gd-DTPA required for routine cranial MR imaging? Radiology 1989;173:231–38 doi:10.1148/radiology.173.1.2781014 pmid:2781014
    CrossRefPubMedWeb of Science
  24. 24.↵
    1. Schwartz GJ,
    2. Brion LP,
    3. Spitzer A.
    The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571–90 doi:10.1016/S0031-3955(16)36251-4 pmid:3588043
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. Hellerstein S.
    Fluids and electrolytes: physiology. Pediatr Rev 1993;14:70–79 doi:10.1542/pir.14-2-70 pmid:8493184
    Abstract/FREE Full Text
  26. 26.↵
    1. Bhargava R,
    2. Hahn G,
    3. Hirsch W, et al
    . Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice. Magn Reson Insights 2013;6:95–111 doi:10.4137/MRI.S12561] pmid:25114547
    CrossRefPubMed
  27. 27.↵
    1. Raschle N,
    2. Zuk J,
    3. Ortiz-Mantilla S, et al
    . Pediatric neuroimaging in early childhood and infancy: challenges and practical guidelines. Ann N Y Acad Sci 2012;1252:43–50 doi:10.1111/j.1749-6632.2012.06457.x pmid:22524338
    CrossRefPubMedWeb of Science
  28. 28.↵
    1. Alcorn J,
    2. McNamara PJ.
    Ontogeny of hepatic and renal systemic clearance pathways in infants, Part I. Clin Pharmacokinet 2002;41:959–98 doi:10.2165/00003088-200241120-00003 pmid:12222995
    CrossRefPubMedWeb of Science
  29. 29.↵
    1. Fernandez E,
    2. Perez R,
    3. Hernandez A, et al
    . Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics 2011;3:53–72 doi:10.3390/pharmaceutics3010053 pmid:24310425
    CrossRefPubMed
  30. 30.↵
    1. Ginsberg G,
    2. Hattis D,
    3. Sonawane B, et al
    . Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol Sci 2002;66:185–200 doi:10.1093/toxsci/66.2.185 pmid:11896285
    CrossRefPubMedWeb of Science
  31. 31.↵
    1. Kunze C,
    2. Mentzel HJ,
    3. Krishnamurthy R, et al
    . Pharmacokinetics and safety of macrocyclic gadobutrol in children aged younger than 2 years including term newborns in comparison to older populations. Invest Radiol 2016;51:50–57 doi:10.1097/RLI.0000000000000204 pmid:26340504
    CrossRefPubMed
  32. 32.↵
    1. Scala M,
    2. Koob M,
    3. de Buttet S, et al
    . A pharmacokinetics, efficacy, and safety study of gadoterate meglumine in pediatric subjects aged younger than 2 years. Invest Radiol 2018;53:70–79 doi:10.1097/RLI.0000000000000412 pmid:28906338
    CrossRefPubMed
  33. 33.↵
    1. Emond S,
    2. Brunelle F.
    Gd-DOTA administration at MRI in children younger than 18 months of age: immediate adverse reactions. Pediatr Radiol 2011;41:1401–06 doi:10.1007/s00247-011-2167-3 pmid:21786126
    CrossRefPubMed
  34. 34.↵
    1. Bhargava R,
    2. Noga M.
    Safety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years: a single-center, observational study. Magn Reson Insights 2013;6:1–12 doi:10.4137/MRI.S10996 pmid:25114540
    CrossRefPubMed
  35. 35.↵
    1. Hamm B,
    2. Thoeni RF,
    3. Gould RG, et al
    . Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994;190:417–23 doi:10.1148/radiology.190.2.8284392 pmid:8284392
    CrossRefPubMed
  36. 36.↵
    1. Kanal E,
    2. Maravilla K,
    3. Rowley HA.
    Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence. AJNR Am J Neuroradiol 2014;35:2215–26 doi:10.3174/ajnr.A3917 pmid:24852287
    Abstract/FREE Full Text
  37. 37.↵
    1. Vaneckova M,
    2. Herman M,
    3. Smith MP, et al
    . The benefits of high relaxivity for brain tumor imaging: results of a multicenter intraindividual crossover comparison of gadobenate dimeglumine with gadoterate meglumine (The BENEFIT Study). AJNR Am J Neuroradiol 2015;36:1589–98 doi:10.3174/ajnr.A4468 pmid:26185325
    Abstract/FREE Full Text
  38. 38.↵
    1. Khouri Chalouhi K,
    2. Papini GD,
    3. Bandirali M, et al
    . Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI. Eur J Radiol 2014;83:1245–49 doi:10.1016/j.ejrad.2014.03.030 pmid:24816087
    CrossRefPubMed
  39. 39.↵
    1. Huang B,
    2. Liang CH,
    3. Liu HJ, et al
    . Low dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0T using high-relaxivity contrast agents. Acta Radiol 2010;51:78–84 doi:10.3109/02841850903350178 pmid:19912078
    CrossRefPubMed
  40. 40.↵
    1. Crisi G,
    2. Filice S,
    3. Erb G, et al
    . Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas. J Magn Reson Imaging 2017;45:500–06 doi:10.1002/jmri.25370 pmid:27373976
    CrossRefPubMed
  41. 41.↵
    1. Filice S,
    2. Crisi G,
    3. Erb G.
    T2*-correction in dynamic contrast-enhanced magnetic resonance imaging of glioblastoma from a half dose of high-relaxivity contrast agent. J Comput Assist Tomogr 2017;41:816–21 doi:10.1097/RCT.0000000000000611 pmid:28708734
    CrossRefPubMed
  42. 42.↵
    1. Murata N,
    2. Gonzalez-Cuyar LF,
    3. Murata K, et al
    . Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Invest Radiol 2016;51:447–53 doi:10.1097/RLI.0000000000000252 pmid:26863577
    CrossRefPubMed
  43. 43.↵
    1. Bussi S,
    2. Penard L,
    3. Bonafè R, et al
    . Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance®) to neonatal and juvenile rats. Regul Toxicol Pharmacol 2018;92:268–27 doi:10.1016/j.yrtph.2017.12.016 pmid:29278694
    CrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 40 (12)
American Journal of Neuroradiology
Vol. 40, Issue 12
1 Dec 2019
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
D.S. Enterline, K.W Martin, H.A Parmar, F.M Triulzi, C. Colosimo
Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants
American Journal of Neuroradiology Dec 2019, 40 (12) 2001-2009; DOI: 10.3174/ajnr.A6319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants
D.S. Enterline, K.W Martin, H.A Parmar, F.M Triulzi, C. Colosimo
American Journal of Neuroradiology Dec 2019, 40 (12) 2001-2009; DOI: 10.3174/ajnr.A6319
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

Patient Safety

  • Safety of Intrathecal Gadobutrol in Various Doses
  • Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol
  • Contrast-Induced Acute Kidney Injury in Radiologic Management of Acute Ischemic Stroke in the Emergency Setting
Show more Patient Safety

Pediatric Neuroimaging

  • Frontal Paraventricular Cysts
  • Sodium MRI in Pediatric Brain Tumors
  • FRACTURE MR in Congenital Vertebral Anomalies
Show more Pediatric Neuroimaging

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire